Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jimai Biological Technology is a life sciences enterprise focused on the production and distribution of high-quality laboratory reagents and the provision of technical services. The company offers an extensive catalog of products, including antibodies, ELISA kits, recombinant proteins, and molecular biology tools designed for research applications. In addition to its product line, Jimai provides contract services such as protein expression, gene synthesis, and immunological assays to support drug discovery and basic research. Headquartered in Shanghai, the firm serves a diverse clientele ranging from academic laboratories to biotechnology and pharmaceutical companies. Jimai Biological Technology is committed to enhancing research efficiency by providing standardized and reliable biological materials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jimai Biological Technology.